Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 2630389

Words CALLIO THERAPEUTICS
Image
Image description
Status registered: Registered/protected
Priority date 26 Aug 2025 (Convention)
Classes 5, 40, 42
Kind Word
Dates
Renewal due 25 Feb 2036
Registration advertised / published 11 May 2026
Entered on Register 11 May 2026
Acceptance advertised / published 03 Mar 2026
Acceptance 03 Mar 2026
Filing 25 Feb 2026
Registered from 25 Feb 2026

Owner Address for service
Callio Operating Co, Inc.
a corporation under the laws of the State of Delaware
Clayton Utz

Goods & Services
Class 5: Pharmaceutical and biological preparations for treating cancer; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies for treating cancer; Pharmaceutical and biological preparations for the prevention, diagnosis and treatment of cancer for clinical, medicinal, therapeutic and diagnostic purposes; Pharmaceutical and biological preparations for use in oncology for treating cancer
Class 40: Custom manufacturing of pharmaceuticals and therapeutic agents for medical use
Class 42: Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases; Scientific investigations for medical purposes; Scientific research in the nature of conducting clinical trials for others

Convention details
Date 26 Aug 2025
Number 99357977
Country UNITED STATES OF AMERICA

Indexing constituents
Word Image